Carriquiry G, Fink V, Koethe JR, Giganti MJ, Jayathilake K, Blevins M, Cahn P, Grinsztejn B, Wolff M, Pape JW. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. J Int AIDS Soc. 2015;18(1).
Yiannoutsos CT, Johnson LF, Boulle A, Musick BS, Gsponer T, Balestre E, Law M, Shepherd BE, Egger M. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Transm Infect. 2012;88(Suppl 2):i33–43.
Grinsztejn B, Luz PM, Pacheco AG, Santos DVG, Velasque L, Moreira RI, Guimarães MRC, Nunes EP, Lemos AS, Ribeiro SR, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One. 2013;8(4):e59768.
Grinsztejn B, Veloso VG, Friedman RK, Moreira RI, Luz PM, Campos DP, Pilotto JH, Cardoso SW, Keruly JC, Moore RD. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS. 2009;23(16):2107–14.
Tancredi MV, Waldman EA. Survival of AIDS patients in Sao Paulo-Brazil in the pre- and post-HAART eras: a cohort study. BMC Infect Dis. 2014;14(1):599.
Guibu IA, Barros MBA, Donalísio MR, Tayra Â, Alves MCGP: Survival of AIDS patients in the southeast and south of Brazil: analysis of the 1998-1999 cohort. Cad Saude Publica. 2011;27:s79-s92.
Coelho L, Grinsztejn B, Castilho JL, De Boni R, Quintana MSB, Campos DP, Ribeiro SR, Pacheco AG, Veloso VG, Luz PM. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. The Lancet HIV. 2016;3(10):e490–8.
Grangeiro A, Escuder MM, Menezes PR, Alencar R, Ayres de Castilho E. Late entry into HIV care: estimated impact on AIDS mortality rates in Brazil, 2003–2006. PLoS One. 2011;6(1):e14585.
United Nations Joint Programme on HIV/AIDS (UNAIDS): UNAIDS Data 2018. Geneva; 2018.
Ministério da Saúde, Brasil: Relatório de Monitoramento Clínico do HIV. Edited by Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, Do HIV/Aids e das Hepatites Virais. Brasília – DF, Brazil; 2018.
Hacker MA, Kaida A, Hogg RS, Bastos FI. The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. Cad Saude Publica. 2007;23:S345–59.
Marins JRP, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, Chequer P, Teixeira PR, Hearst N. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17(11):1675–82.
Teixeira TRA, Gracie G, Malta MS, Bastos FI: Social geography of AIDS in Brazil: identifying patterns of regional inequalities. Cad Saude Publica 2014, 30(2):259–271.
Ministério da Saúde, Brasil: Boletim Epidemiológico HIV AIDS 2017. Edited by Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/Aids e das Hepatites Virais. Brasilia, DF. Brasil; 2017.
Malta M, Bastos FI, da Silva CMFP, Pereira GFM, Lucena FFA, Fonseca MGP, Strathdee SA. Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men. Journal of acquired immune deficiency syndromes (1999). 2009;52(5):629–35.
Lima TA, Beyrer C, Golub JE, Mota JC, Malta MS, Silva CM, Bastos FI: Inequalities in HAART uptake and differential survival according to exposure category in Rio de Janeiro, Brazil. Cad Saude Publica. 2018;34:e00009617.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach [http://www.who.int/hiv/pub/arv/arv-2016/en/]. Geneva; 2016.
Ministry of Health, Brazil: Global AIDS response Progress reporting narrative report – Brazil. Edited by Department of STI, AIDS and Viral Hepatitis. Brasilia, DF. Brazil; 2015.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
Temprano ANRS 12136 Study Group: A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 2015, 2015(373):808–822.
Jia Z, Mao Y, Zhang F, Ruan Y, Ma Y, Li J, Guo W, Liu E, Dou Z, Zhao Y. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort study. Lancet. 2013;382(9899):1195–203.
Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK, Moore R, Roth N. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. The Lancet HIV. 2018;5(8):e438–47.
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014;2(1):e23–34.
Stover J, Gopalappa C, Mahy M, Doherty MC, Easterbrook PJ, Weiler G, Ghys PD. The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy. AIDS. 2014;28:S225–30.
Fonseca MGP, Coeli CM, Lucena FFA, Veloso VG, Carvalho MS. Accuracy of a probabilistic record linkage strategy applied to identify deaths among cases reported to the Brazilian AIDS surveillance database. Cad Saude Publica. 2010;26(7):1431–8.
Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, Brinkhof MWG, Mwango A, Balestre E, Carriquiry G, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011;8(10):e1001111.
Cardoso MN, Caiaffa WT, Mingoti SA. AIDS incidence and mortality in injecting drug users: the AjUDE-Brasil II project. Cad Saude Publica. 2006;22(4):827–37.
Nemes MIB, Melchior R, Basso CR, Castanheira ERL, de Britto e Alves MTSS, Conway S: the variability and predictors of quality of AIDS care services in Brazil. BMC Health Serv Res 2009, 9:51–51.
Fazito E, Cuchi P, Ma Fat D, Ghys PD, Pereira MG, Vasconcelos AMN, Pascom ARP. Identifying and quantifying misclassified and under-reported AIDS deaths in Brazil: a retrospective analysis from 1985 to 2009. Sex Transm Infect. 2012;88(Suppl 2):i86–94.
Ministério da Saúde, Brasil: Saúde Brasil 2014: uma análise da situação de saúde e das causas externas. Edited by Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde; 2015.
Ministério da Saúde, Brasil. SICLOM gerencial [http://azt.aids.gov.br/]. 2018.
Shoko C, Chikobvu D, Bessong PO. A Markov model to estimate mortality due to HIV/AIDS using viral load levels-based states and CD4 cell counts: a principal component analysis approach. Infectious diseases and therapy. 2018;7(4):457–71.
When To Start Consortium: Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009, 373(9672):1352–1363.
Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197(8):1133–44.
The INSIGHT START Study Group: Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015, 373(9):795–807.
He L, Yang J, Ma Q, Zhang J, Xu Y, Xia Y, Chen W, Wang H, Zheng J, Jiang J, et al. Reduction in HIV community viral loads following the implementation of a “treatment as prevention” strategy over 2 years at a population-level among men who have sex with men in Hangzhou, China. BMC Infect Dis. 2018;18(1):62.
Joint United Nations Programme on HIV/AIDS (UNAIDS): 90–90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva; 2014.
Freitas MA, Miranda AE, Pascom ARP, Oliveira SB, Mesquita F, Ford N. Antiretroviral therapy status among people who died of AIDS-related causes from 2009 to 2013 in Brazil: a population-based study. Tropical Med Int Health. 2016;21(11):1452–7.